Upsher Smith Laboratories

Upsher-Smith Laboratories is a US-based pharmaceutical company that specializes in the development, manufacturing, and commercialization of both generic and branded drug products. Founded in 1919, the company has a long-standing reputation in the central nervous system (CNS) space, particularly in the treatment of epilepsy and migraine. In April 2024, Upsher-Smith was acquired by Bora Pharmaceuticals, a leading global contract development and manufacturing organization (CDMO). The company maintains significant manufacturing and R&D facilities in Minnesota, focusing on providing high-quality, affordable medications to patients. Its portfolio includes a diverse range of therapies across cardiology, dermatology, and neurology.